ACTIVE

MILLENIUM PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

105,3 k €

-17.7% YoY

Gross margin

423,9 k €

-6.1% YoY

Equity

288,3 k €

+1.9% YoY

Workforce

4,3 ETP

-2.3% YoY

What does MILLENIUM PHARMA do?

MILLENIUM PHARMA is a Private company with limited liability incorporated in 1999. Its registered office is in Ganshoren. It employs on average 4,3 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0467.724.694

Incorporation

30/11/1999

Legal form

Private company with limited liability

Registered office

Avenue Van Overbeke 153
1083 Ganshoren · BruxellesSee on map

Contributed capital

6 200,00 €

Latest accounts

31/12/2025

Average workforce

4,3 ETP

Joint committees (1)

Signals

ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	423,9 k €	-6.1%	451,2 k €	+20.7%	373,8 k €	+0.7%	371,2 k €	+22.3%	303,6 k €	-7.0%	326,5 k €	-31.4%	476 k €	+118%	218 k €	+11.4%	195,7 k €	-18.8%	241,1 k €	+26.1%	191,2 k €	-9.4%	211,1 k €	+16.3%	181,4 k €	+3.5%	175,3 k €	-13.5%	202,7 k €	+62.1%	125,1 k €	+22.9%	101,8 k €	+28.8%	79 k €	+3.6%	76,3 k €	+14.7%	66,5 k €
EBITDA	176,9 k €	-12.2%	201,4 k €	+34.5%	149,8 k €	+3.0%	145,4 k €	+32.7%	109,5 k €	-28.0%	152,1 k €	-49.7%	302,4 k €	+517%	49 k €	-15.3%	57,8 k €	-38.4%	93,9 k €	+94.9%	48,2 k €	-57.4%	113 k €	+22.6%	92,1 k €	+55.7%	59,2 k €	-51.3%	121,6 k €	+20.2%	101,1 k €	+27.3%	79,5 k €	+6.6%	74,5 k €	+2.4%	72,8 k €	+30.8%	55,7 k €
Operating result	133,1 k €	-18.1%	162,4 k €	+27.7%	127,2 k €	-2.8%	130,8 k €	+35.4%	96,6 k €	-30.3%	138,7 k €	-51.9%	288,4 k €	+712%	35,5 k €	-19.0%	43,9 k €	-46.8%	82,4 k €	+115%	38,4 k €	-63.4%	104,9 k €	+29.6%	80,9 k €	+68.3%	48,1 k €	-56.7%	111,1 k €	+25.2%	88,8 k €	+34.0%	66,2 k €	+8.0%	61,3 k €	+1.5%	60,4 k €	+42.3%	42,5 k €
Net result	105,3 k €	-17.7%	128 k €	+40.5%	91,1 k €	-3.2%	94,1 k €	+46.1%	64,4 k €	-37.4%	102,8 k €	-60.7%	261,4 k €	+931%	25,3 k €	-15.1%	29,8 k €	-42.7%	52,1 k €	+14.7%	45,4 k €	-30.0%	64,9 k €	+26.9%	51,1 k €	+96.8%	26 k €	-58.7%	62,9 k €	+25.1%	50,3 k €	+46.4%	34,4 k €	+11.2%	30,9 k €	+4.7%	29,5 k €	+84.6%	16 k €
Balance sheet
Equity	288,3 k €	+1.9%	283 k €	+11.0%	255 k €	-3.4%	263,9 k €	+20.1%	219,8 k €	-55.6%	495,3 k €	+26.2%	392,5 k €	+29.7%	302,7 k €	-47.3%	574,8 k €	+5.5%	545 k €	+10.6%	492,9 k €	+10.1%	447,6 k €	+426%	85,2 k €	-76.6%	364,6 k €	+7.7%	338,6 k €	+22.8%	275,7 k €	+22.3%	225,4 k €	+18.0%	191 k €	+19.3%	160,1 k €	+22.6%	130,6 k €
Total assets	1,1 M €	+9.5%	1 M €	+19.4%	877,6 k €	+2.3%	857,6 k €	+17.5%	729,8 k €	+9.4%	667,2 k €	-9.5%	736,8 k €	+4.1%	707,7 k €	-17.8%	860,9 k €	+9.8%	783,9 k €	+1.9%	769 k €	+4.9%	733,3 k €	-2.8%	754,5 k €	-12.4%	861,2 k €	+5.8%	814,3 k €	+16.1%	701,6 k €	+12.1%	626 k €	+4.2%	600,9 k €	-7.2%	647,5 k €	+0.5%	644,2 k €
Cash	149,7 k €	+10.8%	135,1 k €	-37.9%	217,4 k €	-11.1%	244,6 k €	+30.3%	187,7 k €	-20.6%	236,4 k €	-20.9%	299 k €	+201%	99,2 k €	-19.1%	122,6 k €	-0.8%	123,6 k €	-2.6%	126,9 k €	+20.7%	105,1 k €	-15.4%	124,3 k €	-14.0%	144,4 k €	+31.5%	109,8 k €	+120%	49,8 k €	+80.9%	27,6 k €	+305%	6,8 k €	-43.9%	12,1 k €	+38.8%	8,7 k €
Debts	859 k €	+12.3%	765 k €	+22.9%	622,6 k €	+4.9%	593,7 k €	+16.4%	510,1 k €	+197%	171,9 k €	-50.1%	344,3 k €	-15.0%	405 k €	+41.6%	286,1 k €	+19.7%	238,9 k €	-13.5%	276,1 k €	-1.7%	280,7 k €	-57.7%	664,4 k €	+49.1%	445,7 k €	+4.9%	424,8 k €	+2.7%	413,4 k €	+6.5%	388,1 k €	-3.5%	402,4 k €	-16.1%	479,9 k €	-5.2%	506,1 k €
Other
Workforce	4,3 ETP	-2.3%	4,4 ETP	+2.3%	4,3 ETP	0.0%	4,3 ETP	-6.5%	4,6 ETP	+27.8%	3,6 ETP	+5.9%	3,4 ETP	0.0%	3,4 ETP	+6.2%	3,2 ETP	+6.7%	3,0 ETP	+7.1%	2,8 ETP	+3.7%	2,7 ETP	+35.0%	2,0 ETP	-20.0%	2,5 ETP	+150%	1,0 ETP	+11.1%	0,9 ETP	+12.5%	0,8 ETP	+300%	0,2 ETP	+100%	0,1 ETP		–

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

AK Herbo Pharma

Director · 0770.728.643

Represented by HAOUZI SANAE

Active

Ended mandates

Chantal DE SAEGER

Director

Ended

Chantal DE SAEGER

Manager

Ended

Chantal Desaeger

Manager

Ended

CHANTAL DESAEGER

Mandate

Ended

At this address

Other companies at this address

Company	CBE no.
BENABAR● Active	0612.962.301
Vereniging van de mede-eigenaars van het gebouw gelegen te 1083 Ganshoren, aan de hoek van Sint Martinuskerkstraat en Van Overbeeklaan 153● Active	0690.846.569

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/08/2026	20/08/2025	23/08/2024	15/06/2023	25/07/2022	27/07/2021
General meeting	01/06/2026	01/06/2025	01/06/2024	01/06/2023	07/06/2022	01/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

22 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	01/06/2026	31/08/2026	French	PDF
Abridged model	31/12/2024	01/06/2025	20/08/2025	French	PDF
Abridged model	31/12/2023	01/06/2024	23/08/2024	French	PDF
Abridged model	31/12/2022	01/06/2023	15/06/2023	French	PDF
Abridged model	31/12/2021	07/06/2022	25/07/2022	French	PDF
Abridged model	31/12/2020	01/06/2021	27/07/2021	French	PDF
Abridged model	31/12/2019	02/06/2020	31/08/2020	French	PDF
Abridged model	31/12/2018	01/06/2019	12/08/2019	French	PDF
Abridged model	31/12/2017	01/06/2018	25/07/2018	French	PDF
Abridged model	31/12/2016	01/06/2017	31/07/2017	French	PDF
Abridged model	31/12/2015	01/06/2016	02/08/2016	French	PDF
Abridged model	31/12/2014	01/06/2015	30/09/2015	French	PDF
Abridged model	31/12/2013	02/06/2014	30/09/2014	French	PDF
Abridged model	31/12/2012	04/06/2013	30/09/2013	French	PDF
Abridged model	31/12/2011	05/06/2012	26/09/2012	French	PDF
Abridged model	31/12/2010	07/06/2011	29/02/2012	French	PDF
Abridged model	31/12/2009	01/06/2010	18/11/2010	French	PDF
Abridged model	31/12/2008	01/06/2009	31/10/2009	French	PDF
Abridged model	31/12/2007	02/06/2008	31/10/2008	French	PDF
Abridged modelCorrection	31/12/2006	07/06/2007	02/10/2007	French	PDF
Abridged model	31/12/2006	07/06/2007	28/08/2007	French	PDF
Abridged modelCorrection	31/12/2005	01/06/2006	30/03/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

AK Herbo Pharma

Director · 0770.728.643

Represented by HAOUZI SANAE

Active

Ended mandates

Chantal DE SAEGER

Director

Ended

Chantal DE SAEGER

Manager

Ended

Chantal Desaeger

Manager

Ended

CHANTAL DESAEGER

Mandate

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates06/01/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates10/12/2021
DEMISSIONS, NOMINATIONS
PDF
Capital / shares03/09/2018
CAPITAL, ACTIONS
PDF
Capital / shares05/05/2014
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates08/09/2011
DEMISSIONS, NOMINATIONS
PDF
Mandates07/12/2006
DEMISSIONS, NOMINATIONS
PDF
Capital / shares16/06/2005
CAPITAL, ACTIONS - ASSEMBLEE GENERALE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025105,3 k €↓
2024
Annual accounts 2024128 k €↑
2023
Annual accounts 202391,1 k €↓
2022
Annual accounts 202294,1 k €↑
2021
Annual accounts 202164,4 k €↓
2020
Annual accounts 2020102,8 k €↓
2019
Annual accounts 2019261,4 k €↑
2018
Annual accounts 201825,3 k €↓
2017
Annual accounts 201729,8 k €↓
2016
Annual accounts 201652,1 k €↑
2015
Annual accounts 201545,4 k €↓
2014
Annual accounts 201464,9 k €↑
2013
Annual accounts 201351,1 k €↑
2012
Annual accounts 201226 k €↓
2011
Annual accounts 201162,9 k €↑
2010
Annual accounts 201050,3 k €↑
2009
Annual accounts 200934,4 k €↑
2008
Annual accounts 200830,9 k €↑
2007
Annual accounts 200729,5 k €↑
2006
Annual accounts 200616 k €
30/11/1999
IncorporationPrivate company with limited liability

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

MILLENIUM PHARMA

Overview

What does MILLENIUM PHARMA do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline